The effect of a thyroid hormone infusion on vasopressor support in critically ill children with cessation of neurologic function

Critical Care Medicine

Volumn 32, Issue 11, 2004, Pages 2318-2322

  Zuppa, Athena F ^a,b,d   Nadkarni, Vinay ^a   Davis, Lauren ^a   Adamson, Peter C ^a   Helfaer, Mark A ^a   Elliott, Michael R ^b   Abrams, John ^c   Durbin, Dennis ^b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Gift of Life Organ Procurem Agency

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Brain death; Pediatric; Thyroid hormone; Vasopressor

Indexed keywords

ADRENALIN; DOBUTAMINE; DOPAMINE; NORADRENALIN; PHENYLEPHRINE; THYROID HORMONE;

ADOLESCENT; ARTICLE; BLOOD PRESSURE; BRAIN DEATH; CONTROLLED STUDY; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; ORGAN DONOR; PRESSOR RESPONSE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; BRAIN DEATH; CHILD; CHILD, PRESCHOOL; CONFOUNDING FACTORS (EPIDEMIOLOGY); CRITICAL ILLNESS; DOBUTAMINE; DOPAMINE; EPINEPHRINE; HEMODYNAMIC PROCESSES; HUMANS; INFANT; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; LIFE SUPPORT CARE; LINEAR MODELS; MULTIVARIATE ANALYSIS; NOREPINEPHRINE; RETROSPECTIVE STUDIES; THYROXINE; TISSUE AND ORGAN HARVESTING; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 8544233544     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000146133.52982.17     Document Type: Article

References (20)

1. De Groot LJ: Dangerous dogmas in medicine: The nonthyroidal illness syndrome. J Clin Endocrinol Metab 1999; 84:151-164
2. Novitzky D, Cooper DK, Barton CI, et al: Triiodothyronine as an inotropic agent after open heart surgery. J Thorac Cardiovasc Surg 1989; 98:972-978
3. Klemperer JD, Klein I, Gomez M, et al: Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med 1995; 333:1522-1527
4. Mullis-Jansson SL, Argenziano M, Corwin S, et al: A randomized double-blind study of the effect of triiodothyronine on cardiac function and morbidity after coronary bypass surgery. J Thorac Cardiovasc Surg 1999; 117:1128-1134
5. Bennett-Guerrero E, Jimenez JL, White WD, et al: Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery. A randomized, double-blind, placebo- controlled trial. Duke T3 study group. JAMA 1996; 275:687-692
6. Bettendorf M, Schmidt KG, Grulich-Henn J, et al: Tri-iodothyrohine treatment in children after cardiac surgery: A double-blind, randomised, placebo-controlled study. Lancet 2000; 356:529-534
7. Portman MA, Fearneyhough C, Ning XH, et al: Triiodothyronine repletion in infants during cardiopulmonary bypass for congenital heart disease. J Thorac Cardiovasc Surg 2000; 120:604-608
8. Jenkins DH, Reilly PM, Schwab CW: Improving the approach to organ donation: a review. World J Surg 1999;23: 644-649
9. Novitzky D, Cooper DK, Morrell D, et al: Change from aerobic to anaerobic metabolism after brain death, and reversal following triiodothyronine therapy. Transplantation 1988;45: 32-36
10. Orlowski JP, Spees EK: Improved cardiac transplant survival with thyroxine treatment of hemodynamically unstable donors: 95.2% graft survival at 6 and 30 months. Transplant Proc 1993; 25:1535
11. Randell TT, Hockerstedt KA: Triiodothyronine treatment is not indicated in brain-dead multiorgan donors: A controlled study. Transplant Proc 1993; 25:1552-1553
12. Salim A, Vassiliu P, Velmahos GC, et al: The role of thyroid hormone administration in potential organ donors. Arch Surg 2001; 136:1377-1380
13. Wernovsky G, Wypij D, Jonas RA, et al: Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation 1995; 92:2226-2235
14. Ligtenberg JJ, Girbes AR, Beentjes JA, et al: Hormones in the critically ill patient: To intervene or not to intervene? Intensive Care Med2001; 27:1567-1577
15. Chopra, IJ: Clinical review 86: Euthyroid sick syndrome: Is it a misnomer? J Clin Endocrinol Metab 1997; 82:329-334
16. Van den Berghe G, de Zegher F, Lauwers P: Dopamine and the sick euthyroid syndrome in critical illness. Clin Endocrinol (Oxf) 1994; 41:731-737
17. Van den Berghe G, de Zegher F, Lauwers P: Dopamine suppresses pituitary function in infants and children. Crit Care Med 1994; 22:1747-1753
18. Lee E, Chen P, Rao H, et al: Effect of acute high dose dobutamine administration on serum thyrotrophin (TSH). Clin Endocrinol (Oxf) 1999; 50:487-492
19. Mainwaring RD, Healy RM, Meier FA, et al: Reduction in levels of triiodothyronine following the first stage of the Norwood reconstruction for hypoplastic left heart syndrome. Cardiol Young 2001; 11:295-300
20. Mainwaring RD, Lamberti JJ, Carter TL Jr, et al: Reduction in triiodothyronine levels following modified Fontan procedure. J Card Surg 1994; 9:322-331